MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,884,980 | +114.8% | 24,292 | +157.3% | 0.02% | +88.9% |
| Q4 2022 | $2,739,960 | -58.8% | 9,440 | -86.2% | 0.01% | -40.0% |
| Q2 2021 | $6,647,000 | -68.5% | 68,235 | -62.1% | 0.02% | -72.7% |
| Q1 2021 | $21,080,000 | +149.1% | 180,215 | +136.8% | 0.06% | +129.2% |
| Q4 2020 | $8,461,000 | +7.0% | 76,111 | +14.2% | 0.02% | -14.3% |
| Q3 2020 | $7,910,000 | -9.7% | 66,622 | -13.9% | 0.03% | -34.9% |
| Q2 2020 | $8,759,000 | +630.5% | 77,342 | +330.5% | 0.04% | +330.0% |
| Q1 2020 | $1,199,000 | +484.9% | 17,967 | +698.5% | 0.01% | +900.0% |
| Q4 2019 | $205,000 | -84.9% | 2,250 | -85.7% | 0.00% | -80.0% |
| Q3 2019 | $1,358,000 | -64.2% | 15,750 | +16.2% | 0.01% | -54.5% |
| Q2 2018 | $3,790,000 | – | 13,549 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 1,402,250 | $93,614,000 | 4.00% |
| Parkman Healthcare Partners LLC | 30,000 | $2,003,000 | 0.93% |
| ARMISTICE CAPITAL, LLC | 216,000 | $14,420,000 | 0.89% |
| Avoro Capital Advisors LLC | 349,000 | $23,299,000 | 0.79% |
| Rock Springs Capital Management LP | 250,000 | $16,690,000 | 0.69% |
| Capital Impact Advisors, LLC | 24,351 | $1,626,000 | 0.68% |
| Baker Brothers Advisors | 1,499,212 | $100,087,000 | 0.62% |
| EWG Elevate Inc. | 11,086 | $740,000 | 0.56% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $801,000 | 0.54% |
| DAFNA Capital Management LLC | 13,600 | $908,000 | 0.38% |